Sterling, Australia

David Otto Willenborg


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1996-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: David Otto Willenborg: Innovator in Anti-Inflammatory Treatments

Introduction

David Otto Willenborg is a notable inventor based in Sterling, Australia. He has made significant contributions to the field of medical treatments, particularly in the area of anti-inflammatory and immunosuppressive therapies. With a total of 3 patents to his name, Willenborg's work has the potential to impact the health and well-being of many.

Latest Patents

Willenborg's latest patents include innovative methods for utilizing castanospermine as an anti-inflammatory and immunosuppressant agent. One of his patents describes a method of anti-inflammatory and/or immunosuppressive treatment for human or other warm-blooded animal patients, which involves administering an effective amount of castanospermine. This approach aims to provide relief and improve the quality of life for patients suffering from various inflammatory conditions.

Career Highlights

David Otto Willenborg is affiliated with The Australian National University, where he conducts research and develops his innovative ideas. His work is characterized by a commitment to advancing medical science and improving treatment options for patients.

Collaborations

Willenborg has collaborated with esteemed colleagues, including Christopher Richard Parish and William Butler Cowden. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic methods.

Conclusion

David Otto Willenborg's contributions to the field of anti-inflammatory treatments through his patents and research at The Australian National University highlight his dedication to medical innovation. His work continues to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…